IMV Inc logo

IMV - IMV Inc Share Price

C$6.82 0.1  2.1%

Last Trade - 07/08/20

Small Cap
Market Cap £240.9m
Enterprise Value £242.5m
Revenue £318k
Position in Universe 371st / 2679
Unlock IMV Revenue
Relative Strength (%)
1m +63.0%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.3%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.13 0.21 0.22 0.48 0.57 1.15 1.08
Balance Sheet
FINANCIAL BRIEF: : For the three months ended 31 March 2020, Imv Inc revenues decreased 17% to C$68K. Net loss increased 63% to C$9.7M. Revenues reflect Subcontract revenue decrease from C$8K to C$0K, Interest income Expenses decrease of 8% to C$68K. Higher net loss reflects Research and development increase of 70% to C$6.8M (expense), General and administrative increase of 55% to C$3M (expense), Accreted interest increase of 9% to C$433K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History


IMV Revenue Unlock IMV Revenue

Net Income

IMV Net Income Unlock IMV Revenue

Normalised EPS

IMV Normalised EPS Unlock IMV Revenue

PE Ratio Range

IMV PE Ratio Range Unlock IMV Revenue

Dividend Yield Range

IMV Dividend Yield Range Unlock IMV Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
IMV EPS Forecasts Unlock IMV Revenue
Profile Summary

IMV Inc. is a clinical-stage biopharmaceutical company focused on immunotherapy in oncology. The Company’s drug delivery platform (DPX) enables the programming of immune cells in vivo. The Company’s lead candidate, DPX-Survivac, is a T cell-activating immunotherapy combining DPX with a specific tumor target: Survivin. DPX-Survivac is a monotherapy in ovarian cancer and in combination with Merck's Keytruda across multiple cancer indications.

Last Annual December 31st, 2019
Last Interim March 31st, 2020
Incorporated May 18, 2007
Public Since April 15, 2004
No. of Shareholders: n/a
No. of Employees: 62
Sector Healthcare
Industry Biotechnology & Medical Research
Exchange Toronto Stock Exchange
Shares in Issue 61,704,072
Free Float (0.0%)
Eligible for
IMV Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for IMV
Upcoming Events for IMV
Wednesday 12th August, 2020
Q2 2020 IMV Inc Earnings Call
Wednesday 12th August, 2020
Q2 2020 IMV Inc Earnings Release
Frequently Asked Questions for IMV Inc
What is the IMV Inc share price?

As of 07/08/20, shares in IMV Inc are trading at C$6.82, giving the company a market capitalisation of £240.9m. This share price information is delayed by 15 minutes.

How has the IMV Inc share price performed this year?

Shares in IMV Inc are currently trading at C$6.82 and the price has moved by 0.112k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the IMV Inc price has moved by 0.109k% over the past year.

What are the analyst and broker recommendations for IMV Inc?

Of the analysts with advisory recommendations for IMV Inc, there are there are currently 1 "buy" , 3 "hold" and 0 "sell" recommendations. The overall consensus recommendation for IMV Inc is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will IMV Inc next release its financial results?

IMV Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the IMV Inc dividend yield?

IMV Inc does not currently pay a dividend.

Does IMV Inc pay a dividend?

IMV Inc does not currently pay a dividend.

When does IMV Inc next pay dividends?

IMV Inc does not currently pay a dividend.

How do I buy IMV Inc shares?

To buy shares in IMV Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of IMV Inc?

Shares in IMV Inc are currently trading at C$6.82, giving the company a market capitalisation of £240.9m.

Where are IMV Inc shares listed? Where are IMV Inc shares listed?

Here are the trading details for IMV Inc:

Country of listing: Canada
Exchange: TOR
Ticker Symbol: IMV
What kind of share is IMV Inc?

Based on an overall assessment of its quality, value and momentum, IMV Inc is currently classified as a Momentum Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a IMV Inc share price forecast 2020?

Shares in IMV Inc are currently priced at C$6.82. At that level they are trading at 17.01% discount to the analyst consensus target price of 0.00.

Analysts covering IMV Inc currently have a consensus Earnings Per Share (EPS) forecast of -0.518 for the next financial year.

How can I tell whether the IMV Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like IMV Inc. Over the past six months, the relative strength of its shares against the market has been 16.76%. At the current price of C$6.82, shares in IMV Inc are trading at 65.72% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the IMV Inc PE Ratio?

We were not able to find PE ratio data for IMV Inc.

Who are the key directors of IMV Inc?

IMV Inc's management team is headed by:

James Hall - IND
Marc Mansour - DRC
Albert Scardino - DRC
Wayne Pisano - IND
Frederic Ors - CEO
Andrew Sheldon - CHM
Shermaine Tilley - IND
Gabriela Rosu - OTH
Pierre Labbe - CFO
Joseph Sullivan - SVP
Julia Gregory - IND
Markus Warmuth - DRC
Marc Jasmin - SDR
Michael Bailey - DRC
Joanne Schindler - OTH
Who are the major shareholders of IMV Inc?

Here are the top five shareholders of IMV Inc based on the size of their shareholding:

Ruffer LLP Investment Advisor/Hedge Fund
Percentage owned: 11.02% (6.80m shares)
CTI Life Sciences Fund, L.P. Corporation
Percentage owned: 8.81% (4.47m shares)
Fonds de Solidarité FTQ Venture Capital
Percentage owned: 8.28% (5.11m shares)
LF Ruffer Absolute Return Fund Mutual Fund
Percentage owned: 5.55% (3.43m shares)
VR Adviser, LLC Venture Capital
Percentage owned: 5.11% (3.15m shares)
Similar to IMV
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.